astemizole | 			
68844-77-9 | 
				
Hismanal | 			
Histaminos | 
				
Paralergin | 			
Laridal | 
				
Retolen | 			
Astemison | 
				
Histamen | 			
Kelp | 
				
Astemizol | 			
Astemizolum | 
				
1-(4-Fluorophenyl)methyl-N-1-2-(4-methoxyphenyl)ethyl-4-piperidinyl-1H-benzimidazol-2-amine | 			
Alermizol | 
				
1-(4-fluorophenyl)methyl-N-1-2-(4-methoxyphenyl)ethylpiperidin-4-ylbenzimidazol-2-amine | 			
R 42512 | 
				
GNF-PF-2461 | 			
UNII-7HU6337315 | 
				
1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole | 			
1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole | 
				
Astemisan | 			
MLS000028667 | 
				
CHEBI:2896 | 			
CHEMBL296419 | 
				
Hestazol | 			
Histazol | 
				
Metodih | 			
Wareezol | 
				
Novo-mastizol A | 			
MFCD00153919 | 
				
1H-Benzimidazol-2-amine, 1-(4-fluorophenyl)methyl-N-1-2-(4-methoxyphenyl)ethyl-4-piperidinyl- | 			
Astemizol German | 
				
NCGC00016913-08 | 			
Metodik | 
				
SMR000058911 | 			
Waruzol | 
				
CAS-68844-77-9 | 			
DSSTox_CID_110 | 
				
7HU6337315 | 			
1-(4-Fluorobenzyl)-2-(1-4-methoxyphenethylpiperidin-4-yl)aminobenzimidazole | 
				
Benzimidazole, 1-(p-fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)- | 			
DSSTox_RID_75373 | 
				
Astemizol INN-Spanish | 			
Astemizolum INN-Latin | 
				
DSSTox_GSID_20110 | 			
R 43512 | 
				
1-(4-Fluorophenyl)methyl-N-{1-2-(4-methoxyphenyl)ethylpiperidin-4-yl}-1H-benzimidazol-2-amine | 			
1H-Benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)- | 
				
R 43,512 | 			
C28H31FN4O | 
				
1-((4-Fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)- 1H-benzimidazol-2-amine | 			
Novo-nastizol a | 
				
3HAstemizole | 			
1-(4-fluorobenzyl)-2-(1-(4-methoxyphenethyl)piperidin-4-yl)aminobenzimidazole | 
				
1-(4-fluorobenzyl)-N-{1-2-(4-methoxyphenyl)ethylpiperidin-4-yl}-1H-benzimidazol-2-amine | 			
1-(p-Fluorobenzyl)-2-1-(p-methoxyphenethyl)-4-piperidylaminobenzimidazole | 
				
1-(4-fluorophenyl)methyl-N-(1-{2-4-(methyloxy)phenylethyl}piperidin-4-yl)-1H-benzimidazol-2-amine | 			
1-(4-fluorophenyl)methyl-N-{1-2-(4-methoxyphenyl)ethylpiperidin-4-yl}-1H-1,3-benzodiazol-2-amine | 
				
CCRIS 7595 | 			
HSDB 6799 | 
				
SR-01000003168 | 			
HISMANAL (TN) | 
				
EINECS 272-441-9 | 			
BRN 4830190 | 
				
Astemizole (JAN/USP/INN) | 			
MJD-30 | 
				
Astemizole,(S) | 			
Astemizole-d3 | 
				
Prestwick_35 | 			
NSC 329963 | 
				
Astemizole USAN:USP:INN:BAN:JAN | 			
Opera_ID_62 | 
				
Spectrum_000448 | 			
Prestwick0_000136 | 
				
Prestwick1_000136 | 			
Prestwick2_000136 | 
				
Prestwick3_000136 | 			
Spectrum2_001732 | 
				
Spectrum3_001072 | 			
Spectrum4_001223 | 
				
Spectrum5_001239 | 			
UPCMLD-DP024 | 
				
cid_2247 | 			
SCHEMBL4385 | 
				
REGID_for_CID_2247 | 			
BSPBio_000212 | 
				
BSPBio_002684 | 			
KBioGR_001686 | 
				
KBioSS_000928 | 			
1H-Benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)eth l)-4-piperidinyl)- | 
				
Astemizole, O-Methyl-3H | 			
MLS001148073 | 
				
DivK1c_000039 | 			
SPECTRUM2300094 | 
				
SPBio_001804 | 			
SPBio_002151 | 
				
BPBio1_000234 | 			
GTPL2603 | 
				
Astemizole, >=98% (HPLC) | 			
DTXSID9020110 | 
				
UPCMLD-DP024:001 | 			
BDBM24226 | 
				
HMS500B21 | 			
KBio1_000039 | 
				
KBio2_000928 | 			
KBio2_003496 | 
				
KBio2_006064 | 			
KBio3_001904 | 
				
NINDS_000039 | 			
HMS1568K14 | 
				
HMS1922L12 | 			
HMS2090F14 | 
				
HMS2093L18 | 			
HMS2095K14 | 
				
HMS2234M17 | 			
HMS3373B08 | 
				
HMS3413N12 | 			
HMS3677N12 | 
				
HMS3712K14 | 			
Pharmakon1600-02300094 | 
				
ZINC601274 | 			
BCP16088 | 
				
EX-A3350 | 			
Tox21_110680 | 
				
Tox21_200095 | 			
CCG-39453 | 
				
NSC329963 | 			
NSC759570 | 
				
STL301859 | 			
AKOS005064371 | 
				
Tox21_110680_1 | 			
DB00637 | 
				
KS-5171 | 			
MCULE-9080712110 | 
				
NSC 759570 | 			
NSC-329963 | 
				
NSC-759570 | 			
1-(4-fluorophenyl)methyl-N-1-2-(4-methoxyphenyl)ethyl-4-piperidylbenzimidazol-2-amine | 
				
IDI1_000039 | 			
QTL1_000010 | 
				
NCGC00016913-01 | 			
NCGC00016913-02 | 
				
NCGC00016913-03 | 			
NCGC00016913-04 | 
				
NCGC00016913-05 | 			
NCGC00016913-06 | 
				
NCGC00016913-07 | 			
NCGC00016913-09 | 
				
NCGC00016913-10 | 			
NCGC00016913-11 | 
				
NCGC00016913-12 | 			
NCGC00016913-14 | 
				
NCGC00018288-01 | 			
NCGC00022520-03 | 
				
NCGC00022520-04 | 			
NCGC00022520-05 | 
				
NCGC00022520-06 | 			
NCGC00022520-07 | 
				
NCGC00257649-01 | 			
HY-12532 | 
				
K146 | 			
SBI-0051891.P002 | 
				
AB00052413 | 			
B7409 | 
				
CS-0011989 | 			
FT-0622497 | 
				
FT-0662309 | 			
ST51014896 | 
				
5318-EP2270008A1 | 			
5318-EP2281815A1 | 
				
5318-EP2292617A1 | 			
5318-EP2292619A1 | 
				
5318-EP2295409A1 | 			
5318-EP2301933A1 | 
				
5318-EP2305640A2 | 			
5318-EP2305659A1 | 
				
5318-EP2308562A2 | 			
5318-EP2311827A1 | 
				
5318-EP2314590A1 | 			
5318-EP2371811A2 | 
				
A13899 | 			
C06832 | 
				
D00234 | 			
AB00052413-18 | 
				
AB00052413_19 | 			
844A779 | 
				
L001015 | 			
Q423437 | 
				
SR-01000003168-2 | 			
SR-01000003168-4 | 
				
W-104654 | 			
BRD-K37249724-001-05-9 | 
				
BRD-K37249724-001-16-6 | 			
Astemizole, United States Pharmacopeia (USP) Reference Standard | 
				
1-(4-fluorobenzyl)-N-(1-(4-methoxyphenethyl)piperidin-4-yl)-1H-benzodimidazol-2-amine | 			
{1-(4-fluorophenyl)methylbenzimidazol-2-yl}{1-2-(4-methoxyphenyl)ethyl(4-p iperidyl)}amine | 
				
1-(4-Fluorobenzyl)-N-(1-2-(4-methoxyphenyl)ethyl-4-piperidinyl)-1H-benzimidazol-2-amine # | 			
1-(4-fluorophenylmethyl)-N-{1-2-(4-methoxyphenyl)ethyl-4-piperidinyl}-1H-benzimidazol-2-amine | 
				
XB7 | 			
 |